|
MRPS16 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.94180000043931E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.22620000003937E-06 |
| Normal-vs-Stage2 |
9.241700E-03 |
| Normal-vs-Stage3 |
1.052650E-01 |
| Normal-vs-Stage4 |
8.449000E-01 |
| Stage1-vs-Stage2 |
9.755400E-01 |
| Stage1-vs-Stage3 |
3.935400E-01 |
| Stage1-vs-Stage4 |
1.160160E-01 |
| Stage2-vs-Stage3 |
5.398200E-01 |
| Stage2-vs-Stage4 |
1.659820E-01 |
| Stage3-vs-Stage4 |
4.433800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.35200000043135E-07 |
| Normal-vs-AfricanAmerican |
5.485000E-03 |
| Normal-vs-Asian |
6.500200E-01 |
| Caucasian-vs-AfricanAmerican |
3.321000E-01 |
| Caucasian-vs-Asian |
5.782600E-01 |
| AfricanAmerican-vs-Asian |
8.923400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.51050002797859E-09 |
| Normal-vs-Female |
3.577600E-01 |
| Male-vs-Female |
6.46279999999555E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.807400E-04 |
| Normal-vs-Extreme_Weight |
3.15930000005515E-06 |
| Normal-vs-Obese |
1.599140E-03 |
| Normal-vs-Extreme_Obese |
5.797200E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.179200E-01 |
| Normal_Weight-vs-Obese |
4.743800E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.173600E-01 |
| Extreme_Weight-vs-Obese |
3.248200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.488990E-01 |
| Obese-vs-Extreme_Obese |
3.522200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.474400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.426800E-04 |
| Normal-vs-Age(61-80Yrs) |
1.12460000001313E-06 |
| Normal-vs-Age(81-100Yrs) |
3.424300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.524100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.658480E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.778100E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.226400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.389830E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.903800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.38999999954592E-07 |
| Normal-VS-Type2 PRCC |
4.542300E-03 |
| Normal-VS-KIRP CIMP |
9.046800E-01 |
| Normal-VS-Unclassified PRCC |
4.986400E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.649600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.602400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.072960E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.911360E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.697000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.734800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.221910E-03 |
| Normal-vs-N1 |
2.543600E-01 |
| Normal-vs-N2 |
8.800200E-01 |
| N0-vs-N1 |
4.223000E-01 |
| N0-vs-N2 |
7.250600E-01 |
| N1-vs-N2 |
8.309200E-01 |
|
|
